We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Enesi Pharma

News List

Enesi Pharma to develop Zika virus vaccine in partnership with University of Adelaide expresspharma
September 07, 2020
It will be in a thermostable, solid dose implant format for transcutaneous delivery via a needle-free device to prevent infection of pregnant women and the resultant congenital effects in the unborn child.
Enesi Pharma partners with Adelaide University for Zika vaccine pharmaceutical-technology
September 04, 2020
UK-based biotechnology firm Enesi Pharma has partnered with the University of Adelaide in Australia to develop a new vaccine against the Zika virus.
Enesi Pharma secures innovate UK funding to manufacture ImplaVax biospectrumasia
September 25, 2019
Enesi Pharma ("Enesi"), the innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, is delighted to announce that it has secured substantial funding from Innovate UK, the UK's innovation agency, under the Bi
Enesi Pharma Adds to Scientific Advisory Board americanpharmaceuticalreview
July 03, 2019
Enesi Pharma has announced the appointment of Dr. Steven Chatfield to its Scientific Advisory Board (SAB).